Morning Group — Competitive Intelligence Brief

Morning Group (Morning Group) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Melatonin receptor agonist. Area: Sleep disorder.

marketed Melatonin receptor agonist Melatonin receptor Sleep disorder Small molecule

Target snapshot

Morning Group (Morning Group) — Rush University Medical Center. Morning Group is a medication that helps regulate sleep-wake cycles.

Comparator set (6 drugs)

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Morning Group TARGET	Morning Group	Rush University Medical Center	marketed	Melatonin receptor agonist	Melatonin receptor
Thymanax	AGOMELATINE	Les Laboratoires Servier	marketed	agomelatine	Melatonin receptor type 1A	2009-01-01
Melatol	MELATONIN	Rad Neurim Pharmaceuticals Eec Sarl	marketed	Adrenocorticotropic Hormone [EPC]	Melatonin receptor type 1B	2007-01-01
Rozerem	RAMELTEON	Takeda	marketed	Melatonin Receptor Agonist [EPC]	Melatonin receptor type 1A	2005-01-01
Ovide	MALATHION	Taro	marketed	Cholinesterase Inhibitor [EPC]	Melatonin receptor type 1A	1982-01-01
transdermal therapeutic system- melatonin.	transdermal therapeutic system- melatonin.	Ain Shams University	marketed	Melatonin receptor agonist	MT1 and MT2 melatonin receptors
Sublingual Melatonin	Sublingual Melatonin	Al-Azhar University	marketed	Melatonin receptor agonist	MT1 and MT2 melatonin receptors

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Melatonin receptor agonist class)

1. Ain Shams University · 2 drugs in this class
2. Al-Azhar University · 1 drug in this class
3. Azienda Ospedaliera Universitaria Policlinico "G. Martino" · 1 drug in this class
4. B.P. Koirala Institute of Health Sciences · 1 drug in this class
5. Federal State Budgetary Institution, V. A. Almazov Federal North-West Medical Research Centre, of the Ministry of Health · 1 drug in this class
6. Hospital San Carlos, Madrid · 1 drug in this class
7. Imperial College London · 1 drug in this class
8. KIMJisun · 1 drug in this class
9. Rush University Medical Center · 1 drug in this class
10. Seoul National University Hospital · 1 drug in this class